Clinical Scorecard: Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy

At a Glance

Key Highlights

• Raman spectroscopy enables continuous, in-situ monitoring of bioprocesses.
• Reduces time delays in quality control from days to minutes.
• Enhances protein stability and formulation assurance.
• Improves drug yield and batch consistency through proactive control.
• Integrates with AI for advanced predictive quality management.

Guideline-Based Recommendations

Diagnosis

• Utilize Raman spectroscopy for rapid structural diagnostics of protein drugs.

Management

• Implement continuous monitoring of key cell culture attributes using Raman probes.

Monitoring & Follow-up

• Adopt real-time visibility for nutrient concentrations and toxic byproducts.

Risks

• Traditional QC delays can lead to catastrophic batch failures.

Patient & Prescribing Data

Patients requiring biopharmaceutical therapies

Raman spectroscopy enhances the safety and efficacy of drug formulations.

Clinical Best Practices

• Transition from retrospective to predictive quality control strategies.
• Use Surface-Enhanced Raman Spectroscopy (SERS) for trace contaminant detection.
• Leverage AI and deep learning for analyzing complex spectral data.

References